Substances · Tryptamine derivatives
5-MeO-MiPT
- Preferred name
- 5-MeO-MiPT
- IUPAC name
- N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2-amine
- Parent CAS number (reference)
- 96096-55-8
- Molecular formula
- C15H22N2O
- Molecular weight
- 246.35 g/mol
- InChIKey
- HEDOODBJFVUQMS-UHFFFAOYSA-N
- PubChem
- CID 2763156
- Source
- PubChem
- Verified synonyms & catalog abbreviations
-
5-Methoxy-N-methyl-N-isopropyltryptamine 5MeOMiPT 5-MeO MiPT
Matching Listings in This Store's Catalog
Verified Neurochemical & Toxicological Intelligence
5-MeO-MiPT (Moxy)
Receptor Telemetry & Mechanism of Action
5-MeO-MiPT combines a 5-methoxy indole with an N-methyl-N-isopropyl side chain. It is a 5-HT1A/5-HT2A agonist with a stimulating, tactile, and erotic bias and relatively modest open-eye visuals compared with 4-HO-MET or 4-HO-MiPT. Body load, nausea, and vasoconstriction are prominent.
Biotransformation & Active Metabolites
The parent compound is active orally, unlike 5-MeO-DMT. MAO still matters: an MAOI is not required for activity and makes the interaction dangerous. It is not 5-MeO-DMT (CAS 1019-45-0) and not 4-HO-MiPT (CAS 77872-43-6).
Temporal Pharmacokinetics
Stimulating, body-heavy, tactile psychedelic with entactogenic warmth, nausea, and fewer geometric visuals than the 4-hydroxy tryptamines.
- Onset 20–40 minutes
- Peak Window 2–3 hours
- Total Window 5–8 hours
- Residual / Half-Life After-effects 2–4 hours of residual stimulation and insomnia. Human plasma half-life is not established.
The oral heavy zone begins at 20 mg, only 5 mg above the top of the strong band (15–20 mg). Light and threshold both start at 3 mg. This is a low-milligram tryptamine, not a 4-HO-MET dose scaled by the similar name.
Quantitative Response Spectrum (Published Literature)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
3 mg
A light mood and body shift, increased tactile notice, still mostly functional.
Mild nausea or stomach tightness and a small pulse increase.
3–7 mg
Warm sociability, erotic tactile enhancement, stimulation, and soft sensory brightening.
Nausea, jaw tension, dilated pupils, and a stimulated rather than sedated body.
7–15 mg
Clear entactogenic and psychedelic effects, enhanced music and touch, some visuals, and a busy mind.
Pronounced nausea early on, vasoconstriction (cold hands), sweating, and a sustained faster heartbeat.
15–20 mg
Intense stimulation, anxiety or mood elevation, tactile overload, and a psychedelic state that is hard to treat as 'just body warmth'.
Strong nausea or vomiting, muscle tension, marked vasoconstriction, and restlessness.
20 mg+
Overwhelming confusion, panic, and a loss of the manageable erotic/stimulant character.
Severe nausea, headache, significant blood-pressure rise, and seizure risk with tramadol, lithium, or an MAOI.
Interaction Matrix & Critical Contraindications
Critical Hazard — Never Combine
Monoamine oxidase inhibition removes the main brake on serotonin while a 5-HT2A agonist is active, producing prolonged, unpredictable intensity, hypertensive reactions, and serotonin toxicity.
Lithium combined with serotonergic psychedelics is associated with seizures and poorly responsive medical emergencies even at otherwise ordinary amounts.
Additive seizure-threshold lowering and serotonergic load. Tramadol is repeatedly flagged on PsychonautWiki interaction lists for this class.
Elevated Hazard — Avoid
Stacks vasoconstriction and confusion. 5-MeO-DMT is a different, much sharper compound and is not a top-up for moxy.
Worsens nausea and judgment across a 5–8 hour course.
Caution / Receptor Attenuation
Often blunt psychedelic intensity while the physical load remains; they are not a reliable 'off switch' and do not make combinations with releasers safe.
Frequently deepens visuals, looping thoughts, and anxiety, including at amounts that felt moderate before cannabis.
Structural Isomer & Sibling Comparison
5-MeO-MiPT is orally active and lasts 5–8 hours at 7–15 mg common, with more stimulation and less color than 4-HO-MiPT (common 15–25 mg). It is far less abrupt than vaporized 5-MeO-DMT (common 6–12 mg, 20–40 minutes) but shares the 5-methoxy warning about MAOIs. The N-isopropyl group is the same idea as in 4-HO-MiPT, not a reason to copy that dose.
Physicochemical Stability & Storage
Form: White, off-white, or tan crystalline powder or clumps as the freebase or a salt. · Salts dissolve in water; the freebase is more soluble in organic solvents and can be vaporized, which PsychonautWiki lists as a separate, not milder, route.
Airtight, cool, and dark. The oral active range begins at 3 mg, so a milligram scale plus a written label is part of storage safety.
Cross-Tolerance & Dependence Profile
Psychedelic tolerance builds quickly, halves in about 3 days, and is near baseline in about 7 days, with cross-tolerance to other 5-HT2A psychedelics. The stimulant edge can encourage repeated exposure; the 20 mg heavy line is close to the strong band, so repeated exposure is how overshoots happen.
Chemical Architecture & Structural Profile
5-MeO-MiPT (N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2-amine) is a reference compound belonging to the Tryptamine derivatives class, characterized by the molecular formula C15H22N2O and a molar mass of 246.35 g/mol. The parent molecule is indexed under CAS registry number 96096-55-8 and in the NCBI PubChem database as CID 2763156 (Standard InChIKey: HEDOODBJFVUQMS-UHFFFAOYSA-N).
Citations
- PubChem — PubChem (2026-11-12)
Reference Toxicology & Safety Profile
In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), 5-MeO-MiPT is indexed within the Substituted tryptamines structural group. Substituted indolealkylamine sensitive to atmospheric oxidation; reference literature notes strict contraindications with monoamine oxidase inhibitors (MAOIs). Dependence liability (PsychonautWiki): not habit-forming. Documented cross-tolerance class: psychedelic. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.
Citations
- PubChem — PubChem (2026-11-12)
Analytical Use & Laboratory Notice
This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.
Citations
- EUDA / National Chemical & Controlled Substance Registry (AE) — National Regulatory Authority (AE) (2026-11-12)